Atlas Trials

AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma

Clinical trial NCT04368182 · UNKNOWN

Trial details

NCT number
NCT04368182
Sponsor
Zhejiang University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2020-04-13
Primary completion
2020-08-31
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.